Á. Szomor

发表

Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?

F. Jardin, F. Cavalli, E. Zucca, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters

L. Papp, D. Máthé, D. Veres, 2022, Frontiers in Oncology.

Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Jesús Martín Sánchez, M. Beksac, H. Goldschmidt, 2018, Clinical lymphoma, myeloma & leukemia.

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.

P. Zinzani, I. Bondarenko, Tongyu Lin, 2021, The Lancet. Oncology.

The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphoma

F. Cavalli, R. Soffietti, C. Doglioni, 2008, British journal of haematology.

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

E. Campo, F. Cavalli, S. Ascani, 2007, Haematologica.

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma

Z. Miltényi, Á. Illés, Á. Szomor, 2020, Annals of Hematology.

[Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma. A Hungarian retrospective study].

Z. Miltényi, Á. Illés, Á. Szomor, 2017, Orvosi hetilap.

Primary bone marrow T-cell anaplastic large cell lymphoma with triple m gradient

G. Delsol, H. Losonczy, T. Saati, 2008, Pathology & Oncology Research.

Genotypic analysis in primary systemic anaplastic large cell lymphoma

G. Delsol, H. Losonczy, T. Saati, 2009, Pathology Oncology Research.

Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation

A. Gratwohl, A. Tichelli, B. Speck, 1997, Annals of Hematology.

Intravascular lymphomatosis of the nervous system

Z. Illés, S. Komoly, F. Kover, 2008, Journal of Neurology.

Use of blood products during the first months of COVID-19 pandemic period: A single center report

A. Vereczkei, A. Miseta, M. Solymár, 2023, Heliyon.

Intravascular lymphoma presenting with neurological signs but diagnosed by prostate biopsy: suspicion as a key to early diagnosis

Z. Illés, G. Fehér, G. Pusch, 2009, European journal of neurology.

[Multidrug resistance in chronic lymphocytic leukemia].

H. Losonczy, B. Kajtár, L. Pajor, 2008, Orvosi hetilap.

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Á. Illés, Á. Bátai, Z. Nagy, 2019, Pathology & Oncology Research.

Changes in adhesion molecule expression and function in B‐cell chronic lymphocytic leukaemia after in vitro interferon‐α stimulation

I. Ocsovszki, J. Milosevits, Á. Szomor, 1995, European journal of haematology.

Expression and function of L-selectin molecules (LECAM-1) in B-cell chronic lymphocytic leukemia.

I. Ocsovszki, J. Milosevits, Á. Szomor, 1994, Haematologica.

[The role of autologous hemopoietic stem cell transplantation in T-cell lymphoma. Hungarian data].

Z. Miltényi, H. Losonczy, P. Reményi, 2017, Orvosi hetilap.

Visceral leishmaniasis in an immunocompetent Hungarian adult patient

B. Tánczos, Á. Szomor, Z. Nemes, 2011 .

The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement

J. Iványi, L. Pajor, P. Jáksó, 2000, Leukemia.

DRUG-INDUCED THROMBOTIC MICROANGIOPATHY CAUSED BY PONATINIB

J. Pammer, A. Mikó, Á. Szomor, 2019 .

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients

Á. Illés, Z. Borbényi, T. Masszi, 2019, International Journal of Hematology.

Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients.

B. Gasztonyi, H. Losonczy, A. Pár, 2000, British journal of haematology.

Factitious hyperkalemia in hematologic disorders

G. Kovacs, A. Miseta, Á. Szomor, 2017, Scandinavian journal of clinical and laboratory investigation.

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden

H. Einsele, H. Johnsen, D. Niederwieser, 2013, Bone Marrow Transplantation.

Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Á. Illés, T. Masszi, Á. Bátai, 2017 .

Penile chloroma in a patient with secondary acute myeloid leukemia

H. Losonczy, T. Tornóczky, Á. Szomor, 2002, European journal of haematology.

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary

Z. Miltényi, Á. Illés, Á. Szomor, 2023, Annals of Hematology.

O-GlcNAcylation in early stages of chronic lymphocytic leukemia; protocol development for flow cytometry.

T. Nagy, A. Miseta, B. Kajtár, 2021, Cancer biomarkers : section A of Disease markers.

[Activation of the nuclear factor kappa B--key role in oncogenesis? Chronic hepatitis C virus infection and lymphomagenesis].

K. Kiss, J. Szeberényi, B. Gasztonyi, 2003, Orvosi Hetilap.

[Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma].

B. Gasztonyi, H. Losonczy, A. Pár, 2000, Orvosi Hetilap.

Absence of Nkx2-3 induces ectopic lymphatic endothelial differentiation associated with impaired extramedullary stress hematopoiesis in the spleen

P. Balogh, Z. Jakus, Á. Szomor, 2023, Frontiers in Cell and Developmental Biology.